Diffuse Large B-Cell Lymphoma (DLBCL) Latest Advances

Epcoritamab for diffuse large B-cell lymphoma in a dialysis-dependent patient.

Journal: Leukemia & lymphoma

Published: January 19, 2026

Real-world treatment patterns and characteristics of patients with diffuse large B-cell lymphoma (DLBCL): a retrospective analysis of US commercial and Medicare claims (2017-2024).

Journal: Leukemia & lymphoma

Published: January 19, 2026

A Case of Diffuse Large B-Cell Lymphoma Detected Due to Ill-Fitting Dentures

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: January 17, 2026

A Case of Diffuse Large B-cell Lymphoma Presenting with Protein-losing Enteropathy During Treatment for Systemic Lupus Erythematosus.

Journal: Internal medicine (Tokyo, Japan)

Published: January 14, 2026

A single-center retrospective analysis of Pola-BR versus R-DeVIC in transplant-ineligible relapsed/refractory diffuse large B-cell lymphoma

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: January 12, 2026

Thromboelastography Combined with Blood D-Dimer in the Prediction of Lower Extremity Venous Thrombosis in Patients with Diffuse Large B-Cell Lymphoma

Journal: Zhongguo shi yan xue ye xue za zhi

Published: January 08, 2026

Historic Real-World Outcomes and Future Benchmarks for Patients with Diffuse Large B-Cell Lymphoma Receiving First- and Second-Line Therapy in Austria - a Large Single-Center Experience.

Journal: Technology in cancer research & treatment

Published: January 08, 2026

Efficacy and Safety of Polatuzumab Vedotin Combined with Chemotherapy in the Treatment of Relapsed and Refractory Diffuse Large B-Cell Lymphoma

Journal: Zhongguo shi yan xue ye xue za zhi

Published: January 08, 2026

Synergistic effects of XPO1 inhibitors combined with CD19 CAR-T cells in TP53-mutated DLBCL.

Journal: Tumori

Published: January 07, 2026

Clinical and histopathological characteristics of 19 cases of orbital diffuse large B-cell lymphoma

Journal: [Zhonghua yan ke za zhi] Chinese journal of ophthalmology

Published: January 06, 2026

Management of relapsed/refractory DLBCL in the era of novel agents and new approaches.

Journal: Leukemia & lymphoma

Published: January 05, 2026

Prognostic and immunomodulatory roles of CD30 in diffuse large B-cell lymphoma: a cell-of-origin- and microenvironment-dependent paradigm.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: December 24, 2025